These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12845620)

  • 1. ECM homeostasis in renal diseases: a genomic approach.
    Eikmans M; Baelde JJ; de Heer E; Bruijn JA
    J Pathol; 2003 Jul; 200(4):526-36. PubMed ID: 12845620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells.
    Kirwan RP; Leonard MO; Murphy M; Clark AF; O'Brien CJ
    Glia; 2005 Dec; 52(4):309-24. PubMed ID: 16078232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
    Qi W; Chen X; Poronnik P; Pollock CA
    Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular events leading to renal tubulointerstitial fibrosis.
    Razzaque MS; Taguchi T
    Med Electron Microsc; 2002 Jun; 35(2):68-80. PubMed ID: 12181648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
    Negri AL
    J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases.
    Eitner F; Floege J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):255-61. PubMed ID: 15816501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers.
    Mas V; Maluf D; Archer K; Yanek K; Mas L; King A; Gibney E; Massey D; Cotterell A; Fisher R; Posner M
    Transplantation; 2007 Feb; 83(4):448-57. PubMed ID: 17318078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression in chronic kidney disease.
    Eddy AA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
    Abraham D
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies.
    Cutroneo KR; White SL; Chiu JF; Ehrlich HP
    J Cell Biochem; 2006 Apr; 97(6):1161-74. PubMed ID: 16408276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA expression profiling as prognostic tool in renal patients: toward nephrogenomics.
    Eikmans M; Baelde HJ; de Heer E; Bruijn JA
    Kidney Int; 2002 Oct; 62(4):1125-35. PubMed ID: 12234282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin: an endogenous renoprotective factor?
    Hewitson TD; Samuel CS
    Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new look at platelet-derived growth factor in renal disease.
    Floege J; Eitner F; Alpers CE
    J Am Soc Nephrol; 2008 Jan; 19(1):12-23. PubMed ID: 18077793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive nephropathy: towards biomarker discovery and gene therapy.
    Chevalier RL
    Nat Clin Pract Nephrol; 2006 Mar; 2(3):157-68. PubMed ID: 16932414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
    Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain.
    Rumberger B; Vonend O; Kreutz C; Wilpert J; Donauer J; Amann K; Rohrbach R; Timmer J; Walz G; Gerke P
    Kidney Blood Press Res; 2007; 30(6):377-87. PubMed ID: 17890868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology.
    Klenkler B; Sheardown H
    Exp Eye Res; 2004 Nov; 79(5):677-88. PubMed ID: 15500826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.